Massive bio completes soc 2 type 1 certification for its ai enabled oncology technology platforms including patient centric clinical trial matching and enrollment services

Massive bio, inc., a leader in precision medicine and artificial intelligence (ai) enabled patient centric clinical trial enrollment, today announced

JOB Ratings Summary

JOB Quant Ranking